First Detection of SARS-CoV-2 B.1.617.2 (Delta) Variant of Concern in a Symptomatic Cat in Spain.
First Detection of SARS-CoV-2 B.1.617.2 (Delta) Variant of Concern in a Symptomatic Cat in Spain.
复制标题
DOI：
10.3389/fvets.2022.841430
复制
发表时间：
2022
影响因子：
3.2
通讯作者：
中科院分区：
文献类型：
--
作者：
自从新冠肺炎大流行开始以来，宠物中自然的和实验性的SARS-CoV-2感染已经被广泛证明。在众多受影响的动物中，猫是最易受影响的物种之一。然而，对动物宿主中的病毒致病性和传播性知之甚少，例如在印度首次发现的B.1.617.2(Delta)变异。在这里，我们已经在一只与新冠肺炎阳性主人一起生活的猫身上发现了B.1.617.2(Delta)挥发性有机化合物。该动物出现轻微症状(打喷嚏)，在口咽拭子中检测到高病毒载量，表明猫的上呼吸道发生了活跃的感染。尽管人类完全接种了SARS-CoV-2疫苗，但还是发生了从主人到猫的传播。这项研究记录了西班牙首次在一只猫身上检测到B.1.165.2 VOC，并强调了对受感染动物进行积极监测和基因组调查的重要性。
Natural and experimental SARS-CoV-2 infection in pets has been widely evidenced since the beginning of the COVID-19 pandemic. Among the numerous affected animals, cats are one of the most susceptible species. However, little is known about viral pathogenicity and transmissibility in the case of variants of concern (VOCs) in animal hosts, such as the B.1.617.2 (Delta) variant first detected in India. Here, we have identified the B.1.617.2 (Delta) VOC in a cat living with a COVID-19 positive owner. The animal presented mild symptoms (sneezing) and a high viral load was detected in the oropharyngeal swab, suggesting that an active infection was occurring in the upper respiratory tract of the cat. Transmission from the owner to the cat occurred despite the human being fully vaccinated against SARS-CoV-2. This study documents the first detection of B.1.165.2 VOC in a cat in Spain and emphasizes the importance of performing active surveillance and genomic investigation on infected animals.
登录
查看更多内容
DOI：
10.3390/v13071379
发表时间：
2021-07-15
期刊：
Viruses
影响因子：
--
作者：
Barroso-Arévalo S;Rivera B;Domínguez L;Sánchez-Vizcaíno JM
通讯作者：
Sánchez-Vizcaíno JM
SARS-COV-2在人类和貂皮之间的貂皮农场上传播，然后回到人类。
DOI：
10.1126/science.abe5901
发表时间：
2021-01-08
期刊：
Science (New York, N.Y.)
影响因子：
--
作者：
Oude Munnink BB;Sikkema RS;Nieuwenhuijse DF;Molenaar RJ;Munger E;Molenkamp R;van der Spek A;Tolsma P;Rietveld A;Brouwer M;Bouwmeester-Vincken N;Harders F;Hakze-van der Honing R;Wegdam-Blans MCA;Bouwstra RJ;GeurtsvanKessel C;van der Eijk AA;Velkers FC;Smit LAM;Stegeman A;van der Poel WHM;Koopmans MPG
通讯作者：
Koopmans MPG
DOI：
10.1016/s2213-2600(21)00005-9
发表时间：
2021-03
期刊：
The Lancet. Respiratory medicine
影响因子：
--
作者：
Kirby T
通讯作者：
Kirby T
影响因子：
4.3
作者：
Hobbs EC;Reid TJ
通讯作者：
Reid TJ
影响因子：
64.8
作者：
Mlcochova P;Kemp SA;Dhar MS;Papa G;Meng B;Ferreira IATM;Datir R;Collier DA;Albecka A;Singh S;Pandey R;Brown J;Zhou J;Goonawardane N;Mishra S;Whittaker C;Mellan T;Marwal R;Datta M;Sengupta S;Ponnusamy K;Radhakrishnan VS;Abdullahi A;Charles O;Chattopadhyay P;Devi P;Caputo D;Peacock T;Wattal C;Goel N;Satwik A;Vaishya R;Agarwal M;Indian SARS-CoV-2 Genomics Consortium (INSACOG);Genotype to Phenotype Japan (G2P-Japan) Consortium;CITIID-NIHR BioResource COVID-19 Collaboration;Mavousian A;Lee JH;Bassi J;Silacci-Fegni C;Saliba C;Pinto D;Irie T;Yoshida I;Hamilton WL;Sato K;Bhatt S;Flaxman S;James LC;Corti D;Piccoli L;Barclay WS;Rakshit P;Agrawal A;Gupta RK
通讯作者：
Gupta RK